Popular
This Week This Month
Storyboards
Sign In
to Vote &
Create Storyboards.
 

Biogen Treads Tricky Path Between Politicians, Investors

Wall Street Journal - 18 Aug 2017 18:43
Biogen is taking a political risk with aggressive multiple sclerosis drug pricing, but the company is under pressure to boost its share price.
Full Article at Wall Street Journal

More Market News
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}     {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}

    • Create Storyboard